Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
BMC Cardiovascular Disorders
Home
About
Articles
Submission Guidelines
Collections
Join the Board
Submit manuscript
Article metrics
Last updated: Fri, 29 Mar 2024 15:00:48 Z
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials